NeueHealth Inc

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

NeueHealth excels in Q1 2024, poised for growth and profitability

NeueHealth's Q1 performance reflects strong financial results and operational achievements across its segments.
The company's solid cash position and credit facility enhancement provide a strong foundation for future growth.
While facing challenges in the ACA business wind-down and industry dynamics, NeueHealth is well-positioned to capitalize on growth opportunities.
Strategic focus on operational efficiency and revenue targets will be key for NeueHealth's success in 2024.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NeueHealth, Inc. engages in the provision of healthcare products and services for consumers and care providers in local markets. It offers individual and family, and Medicare Advantage health plans. It operates through the Bright HealthCare and NeueHealth segments. The Bright HealthCare segment offers commercial and Medicare health plan products. The NeueHealth segment provides care delivery and value-based enablement services. The company was founded by Robert J. Sheehy, Tomas Valdivia, and Kyle Rolfing in 2015 and is headquartered in Doral, FL.

NeueHealth, Inc. (NYSE:NEUE ) Q1 2024 Earnings Conference Call May 8, 2024 8:00 AM ET Company Participants Emily Lombardi - Investor Relations Mike Mikan - President and Chief Executive Officer Jay Matushak - Chief Financial Officer Conference Call Participants Marco Criscuolo - Nephron Research LLC Operator Good morning, everyone, and welcome to the NeueHealth Q1 2024 Earnings Call. My name is Drew, and I'll be the operator for today.

NeueHealth, Inc. (NEUE) Q1 2024 Earnings Call Transcript

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its First Quarter ended March 31, 2024. “We had a strong start to the year, continuing to advance our value-driven, consumer-centric care model as we build on our strong relationships with providers and payors to make high-quality healthcare more accessible and affordable for all populations across the ACA Marketplace, Medicare, a.

NeueHealth Reports First Quarter 2024 Results

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report First Quarter financial results before the financial markets open on Wednesday, May 8, 2024, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number.

NeueHealth to Host First Quarter 2024 Earnings Conference Call on May 8, 2024

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that it entered into an incremental amendment to its credit facility with New Enterprise Associates (“NEA”) that increases the term loan commitment by $30 million on April 8, 2024. The proceeds of the incremental commitment are intended to be used for general corporate purposes, including to support the Company's 2024 strategic priorities. In connecti.

NeueHealth Enters into Amendment to its Credit Facility

NeueHealth, Inc. Q4 2023 Earnings Conference Call March 6, 2024 12:00 AM ET Company Participants Emily Lombardi - Investor Relations Mike Mikan - President and CEO Jay Matushak - CFO Tomas Orozco - Executive Vice President Conference Call Participants Joshua Raskin - Nephron Research Operator Good morning. My name is Drew, and I'll be your conference operator today.

NeueHealth, Inc. (NEUE) Q4 2023 Earnings Call Transcript

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2023. “We achieved significant milestones as a company this past year, completing the sale of our California Medicare Advantage business and fully focusing on where we have proven to have the greatest impact - through our care delivery and provider enablement business,” said Mike.

NeueHealth Reports Fourth Quarter and Full Year 2023 Results

DORAL, Fla.--(BUSINESS WIRE)--NeueHealth (NYSE: NEUE) will report Fourth Quarter financial results Wednesday, March 6, 2024.

NeueHealth to Host Fourth Quarter 2023 Earnings Conference Call on March 6, 2024

News for NeueHealth Inc Stock (NEUE)